Prevention of malignant seeding at drain sites after invasive procedures (surgery and/or thoracoscopy) by hypofractionated radiotherapy in patients with pleural mesothelioma

Acta Oncologica

Volumn 47, Issue 6, 2008, Pages 1094-1098

  Di Salvo, Maurizio ^a   Gambaro, Giuseppina ^a   Pagella, Simonetta ^a   Manfredda, Irene ^a   Casadio, Caterina ^a   Krengli, Marco ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; FLUOROURACIL; GEMCITABINE; OXALIPLATIN; PEMETREXED; RALTITREXED;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ERYTHEMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA MESOTHELIOMA; PLEURODESIS; PRIORITY JOURNAL; SKIN DISCOLORATION; SURVIVAL TIME; THORACOSCOPY; THORAX PAIN; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR GROWTH; VOMITING;

ACTUARIAL ANALYSIS; ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DOSE FRACTIONATION; DRAINAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM SEEDING; PLEURAL NEOPLASMS; PLEURODESIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TALC; THORACOSCOPY; THORACOTOMY; TREATMENT OUTCOME;

EID: 51149096016     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701754182     Document Type: Article

References (20)

1. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63.
2. Zucali PA, Giaccone G. Biology and management of malignant pleural mesothelioma. Eur J Cancer 2006;42:2706-14.
3. Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: Comparison of CTand MR imaging. Am J Roentgenol 1999;172:1039-47.
4. Maggi G, Casadio C, Cianci R, Rena O, Ruffini E. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2001;19:346-50.
5. Sugarbaker DJ, Garcia JP, Richards WG, Harlpole DH Jr, Healy-Baldini E, DeCamp MM Jr, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg 1996;224:288-94.
6. Chapman E, Berenstein EG, Diéguez M, Ortiz Z. Radiotherapy for malignant pleural mesothelioma. Cochrane Database of Systematic Reviews 2006; Issue 3. Article number CD00388.
7. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995;108:754-8.
8. Ung YC, Yu E, Falkson C, Haynes AE, Stys-Norman D, Evans WK, et al. The role of radiation therapy in malignant pleural mesothelioma: A systematic review. Radiother Oncol 2006;80:13-8.
9. Treasure T, Sedrakyan A. Pleural mesothelioma: Little evidence, still time to do trials. Lancet 2004;364:1183-5.
10. Waite K, Gilligan D. The role of radiotherapy in the treatment of malignant pleural mesothelioma. Clin Oncol 2007;19:182-7.
11. Bydder S, Phillips M, Joseph DJ, Cameron F, Spry NA, DeMelker Y, et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer 2004;91:9-10.
12. O'Rourke N, Curto Garcia J, Paul J, Hill J, Lawless C, McMenemin R, et al. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol 2007;84:18-22.
13. Low EM, Khoury GG, Matthews AW, Neville E. Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy. Clin Oncol 1995;7:317-8.
14. West SD, Foord T, Davies RJ. Needle-track metastases and prophylactic radiotherapy for mesothelioma. Respir Med 2006;100:1037-40.
15. Cellerin L, Garry P, Mahe MA, Chailleux E. Malignant pleural mesothelioma: Radiotherapy for the prevention of seeding nodules. Rev Mal Respir 2004;21:53-8.
16. Allen AM, Den R, Wong JS, Zurakowski D, Soto R, Janne PA, et al. Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumectomy. Int J Radiat Oncol Biol Phys 2007;68:1366-74.
17. Ceresoli GL, Locati LD, Ferreri AJ, Cozzarini C, Passoni P, Melloni G, et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer 2001;34:279-87.
18. Hakkinen AM, Laasonen A, Linmainmaa K, Mattson K, Pyrhonen S. Radiosensitivity of mesothelioma cell lines. Acta Oncol 1996;35:451-6.
19. Pinto C, Marini A, De Pangher Manzini V, Benedetti G, Galetta D, Mazzanti P. Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/metotrexate/mytomicin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP I). Lung Cancer 2006;52:199-206.
20. De Ruysscher D, Slotman B. Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: A Dutch-Belgian survey. Radiother Oncol 2003;68:299-302.